Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aziz Zaanan

Showing results (11-20 of 137) with videos related to

Pageof 14
Sort By:
Journal of Gastrointestinal Oncology|December 24, 2015
Implications of mismatch repair-deficient status on management of early stage colorectal cancerHisato Kawakami, Aziz Zaanan, Frank A Sinicrope
The Lancet. Oncology|July 31, 2025
Neurotoxicity-related treatment discontinuations in PRODIGE 51-FFCD-GASTFOX - Authors' replyAziz Zaanan, Karine Le Malicot, Julien Taieb
Drugs|May 24, 2018
Colorectal Cancer: Why Does Side Matter?Claire Gallois, Simon Pernot, Aziz Zaanan, et al.
Annals of Surgical Oncology|November 16, 2022
Outcomes of a Phase II Study of Intraperitoneal Paclitaxel Plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal MetastasesAntoine Mariani, Aziz Zaanan, Olivier Glehen, et al.
British Journal of Cancer|July 30, 2019
Exploring the best treatment options for BRAF-mutant metastatic colon cancerJulien Taieb, Alexandra Lapeyre-Prost, Pierre Laurent Puig, et al.
Current Colorectal Cancer Reports|November 12, 2014
Prognostic Impact of Deficient DNA Mismatch Repair and Mutations in <i>KRAS</i>, and <i>BRAF</i> in Patients with Lymph Node-Positive Colon CancerAziz Zaanan, Jean-Baptiste Bachet, Thierry André, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2024
A fatal case of 5-FU toxicity despite dose adjustment in a patient with a partial DPD deficiency receiving the FLOT regimenAziz Zaanan, Nicolas Pallet, Céline Narjoz, et al.
Clinics and Research in Hepatology and Gastroenterology|November 9, 2015
Advanced small bowel adenocarcinoma: Molecular characteristics and therapeutic perspectivesYosra Zaaimi, Thomas Aparicio, Pierre Laurent-Puig, et al.
Cellular Oncology (Dordrecht, Netherlands)|April 13, 2011
Microsatellite instability in colorectal cancer: from molecular oncogenic mechanisms to clinical implicationsAziz Zaanan, Katy Meunier, Fatiha Sangar, et al.
Molecular Cancer Research : MCR|December 31, 2014
Reversal of Mutant KRAS-Mediated Apoptosis Resistance by Concurrent Noxa/Bik Induction and Bcl-2/Bcl-xL Antagonism in Colon Cancer CellsKoichi Okamoto, Aziz Zaanan, Hisato Kawakami, et al.
Pageof 14

Showing results (11-20 of 137) with videos related to

Sort By:
Pageof 14
Journal of Gastrointestinal Oncology|December 24, 2015
Implications of mismatch repair-deficient status on management of early stage colorectal cancerHisato Kawakami, Aziz Zaanan, Frank A Sinicrope
The Lancet. Oncology|July 31, 2025
Neurotoxicity-related treatment discontinuations in PRODIGE 51-FFCD-GASTFOX - Authors' replyAziz Zaanan, Karine Le Malicot, Julien Taieb
Drugs|May 24, 2018
Colorectal Cancer: Why Does Side Matter?Claire Gallois, Simon Pernot, Aziz Zaanan, et al.
Annals of Surgical Oncology|November 16, 2022
Outcomes of a Phase II Study of Intraperitoneal Paclitaxel Plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal MetastasesAntoine Mariani, Aziz Zaanan, Olivier Glehen, et al.
British Journal of Cancer|July 30, 2019
Exploring the best treatment options for BRAF-mutant metastatic colon cancerJulien Taieb, Alexandra Lapeyre-Prost, Pierre Laurent Puig, et al.
Current Colorectal Cancer Reports|November 12, 2014
Prognostic Impact of Deficient DNA Mismatch Repair and Mutations in <i>KRAS</i>, and <i>BRAF</i> in Patients with Lymph Node-Positive Colon CancerAziz Zaanan, Jean-Baptiste Bachet, Thierry André, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2024
A fatal case of 5-FU toxicity despite dose adjustment in a patient with a partial DPD deficiency receiving the FLOT regimenAziz Zaanan, Nicolas Pallet, Céline Narjoz, et al.
Clinics and Research in Hepatology and Gastroenterology|November 9, 2015
Advanced small bowel adenocarcinoma: Molecular characteristics and therapeutic perspectivesYosra Zaaimi, Thomas Aparicio, Pierre Laurent-Puig, et al.
Cellular Oncology (Dordrecht, Netherlands)|April 13, 2011
Microsatellite instability in colorectal cancer: from molecular oncogenic mechanisms to clinical implicationsAziz Zaanan, Katy Meunier, Fatiha Sangar, et al.
Molecular Cancer Research : MCR|December 31, 2014
Reversal of Mutant KRAS-Mediated Apoptosis Resistance by Concurrent Noxa/Bik Induction and Bcl-2/Bcl-xL Antagonism in Colon Cancer CellsKoichi Okamoto, Aziz Zaanan, Hisato Kawakami, et al.
Pageof 14